Related references
Note: Only part of the references are listed.COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
AV Timoshenko et al.
BRITISH JOURNAL OF CANCER (2006)
Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma
BHA von Rahden et al.
CANCER RESEARCH (2005)
Correlation of hypoxia inducible factor-1α with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer
M Katsuta et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2005)
Molecular and cellular mechanisms of lymphangiogenesis
MAA Al-Rawi et al.
EJSO (2005)
COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma
PA Kyzas et al.
MODERN PATHOLOGY (2005)
Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression
WWL Choi et al.
MODERN PATHOLOGY (2005)
Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation:: A novel-mechanism of lymphangiogenesis in lung adenocarcinoma
JL Su et al.
CANCER RESEARCH (2004)
Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer
SF Schoppmann et al.
ANNALS OF SURGERY (2004)
Lack of lymphangiogenesis during breast carcinogenesis
MM Vleugel et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation
P Saharinen et al.
TRENDS IN IMMUNOLOGY (2004)
Molecular targeting of lymphatics for therapy
SA Stacker et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Cyclooxygenases in cancer: progress and perspective
S Zha et al.
CANCER LETTERS (2004)
High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer
P Bono et al.
CLINICAL CANCER RESEARCH (2004)
Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma
JS Byeon et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Lymphangiogenesis and tumor metastasis
MS Pepper et al.
CELL AND TISSUE RESEARCH (2003)
Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up
Y Nakamura et al.
MODERN PATHOLOGY (2003)
Role of cyclooxygenase-2 in breast cancer
B Singh et al.
JOURNAL OF SURGICAL RESEARCH (2002)
A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors
HJ Kahn et al.
LABORATORY INVESTIGATION (2002)
Lymphangiogenesis and cancer metastasis
SA Stacker et al.
NATURE REVIEWS CANCER (2002)
Lymphatic metastasis in the absence of functional intratumor lymphatics
TP Padera et al.
SCIENCE (2002)
Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer
C Costa et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis
JG Rozic et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
M Skobe et al.
NATURE MEDICINE (2001)
Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer
J Kinoshita et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Share Paper
